These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia. Ibrahim S; Jilani I; O'Brien S; Rogers A; Manshouri T; Giles F; Faderl S; Thomas D; Kantarjian H; Keating M; Albitar M Cancer; 2003 Apr; 97(8):1914-9. PubMed ID: 12673718 [TBL] [Abstract][Full Text] [Related]
6. Simultaneous expression of CD38 and its ligand CD31 by chronic lymphocytic leukemia B-cells: anecdotal observation or pathogenetic hypothesis for the clinical outcome? Morabito F; Mangiola M; Stelitano C; Deaglio S; Callea V; Malavasi F Haematologica; 2003 Mar; 88(3):354-5. PubMed ID: 12651280 [No Abstract] [Full Text] [Related]
7. Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia: correlation with CD38 expression. Ottaggio L; Viaggi S; Zunino A; Zupo S; Rossi E; Spriano M; Abbondandolo A; Ferrarini M Haematologica; 2003 Jul; 88(7):769-77. PubMed ID: 12857555 [TBL] [Abstract][Full Text] [Related]
8. Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil. Morabito F; Mangiola M; Stelitano C; Deaglio S; Callea V; Malavasi F Haematologica; 2002 Feb; 87(2):217-8. PubMed ID: 11836173 [TBL] [Abstract][Full Text] [Related]
9. The use of CD38 expression by monoclonal B lymphocytes as a prognostic factor in B-cell chronic lymphocytic leukemia. Boonstra JG; von't Veer MB; Gratama JW J Biol Regul Homeost Agents; 2004; 18(3-4):340-6. PubMed ID: 15786702 [TBL] [Abstract][Full Text] [Related]
10. CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells. Deaglio S; Capobianco A; Bergui L; Dürig J; Morabito F; Dührsen U; Malavasi F Blood; 2003 Sep; 102(6):2146-55. PubMed ID: 12763926 [TBL] [Abstract][Full Text] [Related]
11. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients. Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155 [TBL] [Abstract][Full Text] [Related]
12. Relationship between cell surface expression of CD38 and of vascular endothelial growth factor in B-cell chronic lymphocytic leukemia. McCabe D; O'Regan K; Murphy PT Leuk Res; 2004 Nov; 28(11):1239-40. PubMed ID: 15380351 [No Abstract] [Full Text] [Related]
13. CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia. Dürig J; Naschar M; Schmücker U; Renzing-Köhler K; Hölter T; Hüttmann A; Dührsen U Leukemia; 2002 Jan; 16(1):30-5. PubMed ID: 11840260 [TBL] [Abstract][Full Text] [Related]
14. Cryptic deletion involving the ATM locus at 11q22.3 approximately q23.1 in B-cell chronic lymphocytic leukemia and related disorders. Eclache V; Caulet-Maugendre S; Poirel HA; Djemai M; Robert J; Lejeune F; Raphaël M Cancer Genet Cytogenet; 2004 Jul; 152(1):72-6. PubMed ID: 15193446 [TBL] [Abstract][Full Text] [Related]
15. Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro. Morabito F; Mangiola M; Rapezzi D; Zupo S; Oliva BM; Ferraris AM; Spriano M; Rossi E; Stelitano C; Callea V; Cutrona G; Ferrarini M Haematologica; 2003 Aug; 88(8):864-73. PubMed ID: 12935974 [TBL] [Abstract][Full Text] [Related]
16. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031 [TBL] [Abstract][Full Text] [Related]
17. Quantification improves the prognostic value of CD38 expression in B-cell chronic lymphocytic leukaemia. Mainou-Fowler T; Dignum H; Taylor PR; Dickinson AM; Saunders PW; Proctor SJ; Summerfield GP Br J Haematol; 2002 Sep; 118(3):755-61. PubMed ID: 12181042 [TBL] [Abstract][Full Text] [Related]
18. Quantification of CD38 expression in B-cell chronic lymphocytic leukemia (B-CLL): a comparison between antibody binding capacity (ABC) and relative median fluorescence (RMF). Dignum HM; Summerfield GP; Proctor SJ; Mainou-Fowler T Leuk Lymphoma; 2004 Jun; 45(6):1167-73. PubMed ID: 15359996 [TBL] [Abstract][Full Text] [Related]
19. CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival. Deaglio S; Vaisitti T; Bergui L; Bonello L; Horenstein AL; Tamagnone L; Boumsell L; Malavasi F Blood; 2005 Apr; 105(8):3042-50. PubMed ID: 15613544 [TBL] [Abstract][Full Text] [Related]
20. Laboratory, morphologic, and immunophenotypic correlates of surface immunoglobulin heavy chain isotype expression in B-cell chronic lymphocytic leukemia. Shen PU; Fuller SG; Rezuke WN; Sherburne BJ; DiGiuseppe JA Am J Clin Pathol; 2001 Dec; 116(6):905-12. PubMed ID: 11764081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]